ACR Convergence 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences
R-Pharm at ACR Convergence 2026
Nov 6–11, 2026 Orlando, FL ~15k attendees Website
R-Pharm brings 4 presentations to ACR Convergence 2026 in Orlando. Its program centres on olokizumab, an IL-6 inhibitor, in rheumatoid arthritis and polymyalgia rheumatica. It also looks at anemia correction, microRNA changes linked to treatment response, and treating depression alongside IL-6 therapy.
| Organization | ACR Convergence 2026 Attendance |
|---|---|
R-Pharm Moscow, Russia | |
A pharmaceutical company developing and manufacturing medicines. | Poster Mon Nov 9 10:30am–12:30pm Poster Mon Nov 9 10:30am–12:30pm Poster Tue Nov 10 10:30am–12:30pm |
Find decision makers at R-Pharm
Tell us what you sell and we’ll find the people at R-Pharm most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American College of Rheumatology (ACR). Organization details are derived from the ACR’s published program and exhibitor floor plan, and each organization’s own website. Submit a correction